AI生物大模型赋能前沿生命科学

Core Insights - The strategic partnership between Cloud Bio and Koyan Pharmaceutical aims to integrate AI-driven biological models with advanced skin science, focusing on the commercialization of extracellular matrix (ECM) aging intervention technologies [1][2][4] Group 1: Partnership and Objectives - Cloud Bio's skincare brand Beast Bella has established a joint laboratory with Koyan Pharmaceutical to enhance the development of products targeting skin aging [1][4] - The collaboration signifies a deep integration of AI biological models with cutting-edge skin science, aiming to redefine "medical-grade skincare" in the AI era [2][4] Group 2: Research and Development Framework - The R&D system of Beast Bella is built on Cloud Bio's AI infrastructure, including the BEAST cell sensing platform and BELLA virtual skin cell AI platform, enabling intelligent iteration of formulations and safety warnings based on aging science data [2][5] - The joint laboratory will focus on three main pathways for aging intervention: enhancing ECM aging intervention technology, establishing medical-grade efficacy and safety evaluation standards, and accelerating the application of biopharmaceutical technologies in skincare [5][6] Group 3: Industry Impact and Future Outlook - The partnership aims to create a new standard in cosmetics by combining rigorous biopharmaceutical applications with AI efficiency, moving away from concept marketing to evidence-based science [6][7] - The joint laboratory is expected to serve as an engine for continuous innovation, transforming advanced life science research into effective and safe skincare solutions for a growing high-awareness consumer base [7]